AI specialist Recursion nabs multibillion-dollar Roche partn...

Roche has formed a decade-long alliance with Recursion Pharma that will focus on using machine learning and "industrialised" drug discovery to find new neuroscience and cancer drugs.

GSK pumps £30m into a new Oxford University partnership

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicine

With Alzheimer's market opening up, Lilly forms neuroscience...

Eli Lilly is one of the front runners in the bid to follow Biogen and Eisai onto the market with an anti-amyloid drug for Alzheimer's disease, and its preparing the ground with a restructur

3rd Annual Blood-Brain Barrier Summit

Enhance Drug Delivery Across the Blood-Brain Barrier

The 3rd Annual Blood-Brain Barrier Summit Returns in August ...

Specialized Digital Conference for Biopharma

Merck builds in CNS diseases with $576m Calporta buy